Sector News

Novozymes appoints Ester Baiget from Dow as new CEO

October 31, 2019
Chemical Value Chain

Enzymes maker Novozymes said on Wednesday it had appointed Ester Baiget from Dow as the firm looks to boost its sales growth on the back of several profit warnings.

Baiget is currently business president of Dow’s Industrial Solutions business unit and will take over the reins at the Danish firm from February 2020.

Novozymes, which has repeatedly cut it 2019 sales outlook, said earlier this month that current CEO Peder Holk Nielsen would step down as it was time to “bring in new leadership”.

By Andreas Mortensen

Source: Reuters

Related News

April 9, 2020

Global chem trade flows shift to Asia as pandemic causes demand collapse in the West

Chemical Value Chain

Asia may end up as a dumping ground for many chemicals from the world over, as US and European markets slump and economies slide into recession. With demand drying up […]

April 7, 2020

ExxonMobil reduces 2020 capex by $10 billion

Chemical Value Chain

ExxonMobil will reduce 2020 capital spending by 30% and lower cash operating expenses by 15% in response to low commodity prices resulting from oversupply and demand weakness from the coronavirus […]

April 7, 2020

Air Liquide enters exclusive talks with EQT for Schülke sale

Chemical Value Chain

Air Liquide says it has entered into exclusive negotiations with private equity firm EQT (Stockholm, Sweden) for the potential sale to EQT of its wholly owned subsidiary Schülke & Mayr […]